275 related articles for article (PubMed ID: 8671718)
1. Aflatoxin B1 induced lacI mutation in liver and kidney of transgenic mice C57BL/6N: effect of phorone.
Autrup H; Jørgensen EC; Jensen O
Mutagenesis; 1996 Jan; 11(1):69-73. PubMed ID: 8671718
[TBL] [Abstract][Full Text] [Related]
2. Species-specific differences in hepatic mutant frequency and mutational spectrum among lambda/lacI transgenic rats and mice following exposure to aflatoxin B1.
Dycaico MJ; Stuart GR; Tobal GM; de Boer JG; Glickman BW; Provost GS
Carcinogenesis; 1996 Nov; 17(11):2347-56. PubMed ID: 8968048
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen induces G:C-->T:A mutations in the cII gene in the liver of lambda/lacI transgenic rats but not at 5'-CpG-3' dinucleotide sequences as found in the lacI transgene.
Davies R; Gant TW; Smith LL; Styles JA
Carcinogenesis; 1999 Jul; 20(7):1351-6. PubMed ID: 10383911
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous mutations in lacI-containing lambda lysogens derived from transgenic mice: the observed patterns differ in liver and spleen.
Knöll A; Jacobson DP; Kretz PL; Lundberg KS; Short JM; Sommer SS
Mutat Res; 1994 Nov; 311(1):57-67. PubMed ID: 7526175
[TBL] [Abstract][Full Text] [Related]
5. Mutation frequency in the lacI gene of liver DNA from lambda/lacI transgenic mice following the interaction of PCBs with iron causing hepatic cancer and porphyria.
Davies R; Clothier B; Smith AG
Mutagenesis; 2000 Sep; 15(5):379-83. PubMed ID: 10970442
[TBL] [Abstract][Full Text] [Related]
6. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
7. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice.
Stuart GR; Gorelick NJ; Andrews JL; de Boer JG; Glickman BW
Environ Mol Mutagen; 1996; 28(4):385-92. PubMed ID: 8991067
[TBL] [Abstract][Full Text] [Related]
8. Intralaboratory optimization and standardization of mutant screening conditions used for a lambda/lacI transgenic mouse mutagenesis assay (I).
Rogers BJ; Provost GS; Young RR; Putman DL; Short JM
Mutat Res; 1995 Mar; 327(1-2):57-66. PubMed ID: 7870099
[TBL] [Abstract][Full Text] [Related]
9. Interlaboratory comparison: liver spontaneous mutant frequency from lambda/lacI transgenic mice (Big Blue) (II).
Young RR; Rogers BJ; Provost GS; Short JM; Putman DL
Mutat Res; 1995 Mar; 327(1-2):67-73. PubMed ID: 7870100
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous and ENU-induced mutation spectra at the cII locus in Big Blue Rat2 embryonic fibroblasts.
Watson DE; Cunningham ML; Tindall KR
Mutagenesis; 1998 Sep; 13(5):487-97. PubMed ID: 9800194
[TBL] [Abstract][Full Text] [Related]
11. Reporter gene transgenic mice as a tool for analyzing the molecular mechanisms underlying experimental carcinogenesis.
Nishikawa A; Suzuki T; Masumura K; Furukawa F; Miyauchi M; Nakamura H; Son HY; Nohmi T; Hayashi M; Hirose M
J Exp Clin Cancer Res; 2001 Mar; 20(1):111-5. PubMed ID: 11370817
[TBL] [Abstract][Full Text] [Related]
12. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene.
Hayward JJ; Shane BS; Tindall KR; Cunningham ML
Carcinogenesis; 1995 Oct; 16(10):2429-33. PubMed ID: 7586147
[TBL] [Abstract][Full Text] [Related]
13. Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice.
Skopek TR; Kort KL; Marino DR; Mittal LV; Umbenhauer DR; Laws GM; Adams SP
Environ Mol Mutagen; 1996; 28(4):376-84. PubMed ID: 8991066
[TBL] [Abstract][Full Text] [Related]
14. Ethylnitrosourea-induced mutation and molecular analysis of transgenic mice containing the gpt shuttle vector.
Yamada T; Yamamoto R; Kaneko H; Yoshitake A
Mutat Res; 1999 Apr; 441(1):59-72. PubMed ID: 10224323
[TBL] [Abstract][Full Text] [Related]
15. Specific mutational spectrum of dimethylnitrosamine in the lacI transgene of Big Blue C57BL/6 mice.
Wang X; Suzuki T; Itoh T; Honma M; Nishikawa A; Furukawa F; Takahashi M; Hayashi M; Kato T; Sofuni T
Mutagenesis; 1998 Nov; 13(6):625-30. PubMed ID: 9862195
[TBL] [Abstract][Full Text] [Related]
16. Comparison of mutant frequencies at the transgenic lambda LacI and cII/cI loci in control and ENU-treated Big Blue mice.
Zimmer DM; Harbach PR; Mattes WB; Aaron CS
Environ Mol Mutagen; 1999; 33(3):249-56. PubMed ID: 10334627
[TBL] [Abstract][Full Text] [Related]
17. Tissue-specific mutant frequencies and mutational spectra in cyclophosphamide-treated lacI transgenic mice.
Gorelick NJ; Andrews JL; deBoer JG; Young R; Gibson DP; Walker VE
Environ Mol Mutagen; 1999; 34(2-3):154-66. PubMed ID: 10529740
[TBL] [Abstract][Full Text] [Related]
18. The in vivo mutagenicity and mutational spectrum at the lacI transgene recovered from the spleens of B6C3F1 lacI transgenic mice following a 4-week inhalation exposure to 1,3-butadiene.
Recio L; Pluta LJ; Meyer KG
Mutat Res; 1998 Jun; 401(1-2):99-110. PubMed ID: 9639685
[TBL] [Abstract][Full Text] [Related]
19. Inhalation of benzene leads to an increase in the mutant frequencies of a lacI transgene in lung and spleen tissues of mice.
Mullin AH; Rando R; Esmundo F; Mullin DA
Mutat Res; 1995 Mar; 327(1-2):121-9. PubMed ID: 7870081
[TBL] [Abstract][Full Text] [Related]
20. Comparison of mutant frequencies and types of mutations induced by thiotepa in the endogenous Hprt gene and transgenic lacI gene of Big Blue rats.
Chen T; Aidoo A; Manjanatha MG; Mittelstaedt RA; Shelton SD; Lyn-Cook LE; Casciano DA; Heflich RH
Mutat Res; 1998 Jul; 403(1-2):199-214. PubMed ID: 9726020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
